已收盘 05-15 16:00:00 美东时间
+0.160
+5.48%
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Nyxoah (NASDAQ:NYXH) held its first-quarter earnings conference call on Tuesday...
05-13 05:35
Nyxoah (NASDAQ:NYXH) sees FY2026 sales of $42.156 million-$46.840 million vs $37.200 million analyst estimate.
05-13 04:21
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 31.75 percent increase over losses of $(0.63) per share from the same
05-13 04:16
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Stifel analyst Jonathan Block downgrades Nyxoah (NASDAQ:NYXH) from Buy to Hold and lowers the price target from $8 to $5.
05-12 18:58
今日重点评级关注:Ascendiant Capital:维持Allarity Therapeutics"买入"评级,目标价从9.5美元升至9.75美元;Citizens:维持戴夫"跑赢大市"评级,目标价从310美元升至335美元
04-13 14:07
Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:NYXH) with a Buy and lowers the price target from $10 to $8.
04-10 21:47